Vaccine Adjuvants Market Scope And Analysis

Report Code : TIPRE00004430
Category : Life Sciences

Status : Published
No. of Pages : 155

Buy Now

Vaccine Adjuvants Market Scope and Analysis by 2031

Buy Now

Vaccine Adjuvants Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 2,482.39 Million
Market Size by 2030	US$ 6,931.55 Million
Global CAGR (2022 - 2030)	13.7%
Historical Data	2020-2021
Forecast period	2022-2030
Segments Covered	By Adjuvant Class Mineral Salt Adjuvant Emulsion Adjuvant Liposome Adjuvant By Type Human Vaccine Adjuvant Veterinary Vaccine Adjuvant
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	SPI Pharma Inc GSK Plc CSL Ltd Seppic SA Hawaii Biotech Inc Dynavax Technologies Corp InvivoGen SAS Croda International Plc Novavax Inc Phibro Animal Health Corp

Vaccine Adjuvants Market News and Recent Developments

The vaccine adjuvants market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the vaccine adjuvants market are listed below:

SPI Pharma Inc and Q-Vant Biosciences Inc partnered to combines Q-Vant's leadership in sustainable saponin extraction technology with SPI's global reach and servicing expertise in the pharmaceutical industry. This includes investment in expanding Q-Vant’s proprietary 100% sustainable Q-SAP technology and an exclusive commercial agreement to accelerate the global adoption of their saponin adjuvants for veterinary and human vaccine formulations. (Source: SPI Pharma Inc, Press Release, October 2023)
Seppic launched MONTANIDE GEL P PR, an aqueous adjuvant based on a polymeric technology dedicated to avian injectable vaccines, meeting the need for innocuity in the avian market. In addition, MONTANIDE GEL P PR is particularly stable and can resist destabilising antigenic media frequently used in avian vaccines. (Source: Seppic, Press Release, May 2024)

Vaccine Adjuvants Market Report Coverage and Deliverables

The “Vaccine Adjuvants Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Vaccine adjuvants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Vaccine adjuvants market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Vaccine adjuvants market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Vaccine Adjuvants market
Detailed company profiles